Hot Pursuit     27-Jun-24
Zydus Lifesciences Ltd drops for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 1054.4, down 1.07% on the day as on 13:19 IST on the NSE. The stock jumped 81.03% in last one year as compared to a 26.38% rally in NIFTY and a 43.07% spurt in the Nifty Pharma index.

Zydus Lifesciences Ltd fell for a fifth straight session today. The stock is quoting at Rs 1054.4, down 1.07% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.46% on the day, quoting at 23977.8. The Sensex is at 79080.79, up 0.52%.Zydus Lifesciences Ltd has gained around 0.14% in last one month.Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has increased around 1.43% in last one month and is currently quoting at 19545.35, down 0.28% on the day. The volume in the stock stood at 9.4 lakh shares today, compared to the daily average of 14.83 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 1056.95, down 0.95% on the day. Zydus Lifesciences Ltd jumped 81.03% in last one year as compared to a 26.38% rally in NIFTY and a 43.07% spurt in the Nifty Pharma index.

The PE of the stock is 31.12 based on TTM earnings ending March 24.

Previous News
  Zydus Lifesciences Ltd spurts 2.26%, rises for third straight session
 ( Hot Pursuit - 04-Jul-24   13:05 )
  Zydus Life gets USFDA nod for Zituvimet XR tablets
 ( Hot Pursuit - 19-Jul-24   11:53 )
  Zydus Life rises on USFDA nod for dyskinesia treatment drug
 ( Hot Pursuit - 28-Aug-24   09:57 )
  Zydus Life hits life high as unit gets USFDA nod for manufacturing APIs
 ( Hot Pursuit - 07-Mar-24   13:07 )
  Zydus receives USFDA approval for Zituvimet™ XR tablets
 ( Corporate News - 19-Jul-24   13:58 )
  Zydus Lifesciences fixes record date for buyback of shares
 ( Market Beat - Reports 09-Feb-24   17:03 )
  Zydus receives USFDA final approval for Cyclophosphamide Capsules
 ( Corporate News - 14-Dec-23   18:57 )
  Zydus Life inks exclusive licensing & supply agreement for Palbociclib Tablets with Synthon
 ( Hot Pursuit - 19-Jan-24   09:46 )
  Zydus Lifesciences receives EIR for injectables manufacturing facility
 ( Corporate News - 13-Sep-23   13:54 )
  Zydus Lifesciences completes acquisition of Watson Pharma's unit
 ( Corporate News - 08-Aug-23   09:10 )
  Board of Zydus Lifesciences approves buyback of Rs 600 cr
 ( Corporate News - 09-Feb-24   17:50 )
Other Stories
  Tata Motors total sales drop 11% YoY in Sept’24
  01-Oct-24   15:33
  Vipul Organics hits all-time high after board OKs Rs 25 cr right issue
  01-Oct-24   15:06
  Magellanic Cloud Ltd leads losers in 'A' group
  01-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  01-Oct-24   14:45
  GE Power India rises on bagging order worth Rs 240-cr
  01-Oct-24   14:41
  Volumes jump at Caplin Point Laboratories Ltd counter
  01-Oct-24   14:30
  TVS Motor registers 20% growth in September 2024 sales; Q2 total sales at 12.28 lakh units
  01-Oct-24   14:07
  Oil and Gas shares slide
  01-Oct-24   14:00
  Telecom shares fall
  01-Oct-24   14:00
  Real Estate stocks slide
  01-Oct-24   14:00
Back Top